SELECTIS HEALTH, INC.
SELECTIS HEALTH, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash | - | - | - | - | - | - | 1 | - | - | - | 2 | - | |||||
Cash And Cash Equivalents At Carrying Value | 1 | 1 | 0 | 1 | 1 | 1 | - | 3 | 1 | 1 | 2 | 1 | |||||
Accounts Receivable Net Current | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | |||||
Other Receivables Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | 6 | 4 | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | 10 | 8 | 4 | 4 | 5 | 4 | 4 | 6 | 4 | 5 | 6 | 10 | |||||
Assets Noncurrent | |||||||||||||||||
Restricted Cash Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 18 | 23 | 27 | 28 | 28 | 28 | 28 | 29 | 34 | 34 | 34 | 35 | |||||
Goodwill | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 30 | 33 | 33 | 34 | 35 | 33 | 34 | 37 | 40 | 41 | 42 | 47 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 7 | 6 | 7 | 8 | 8 | 7 | 6 | 7 | 6 | 6 | 4 | 6 | |||||
Dividends Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Debt Current | 4 | 11 | 12 | 11 | 11 | 11 | 13 | 11 | 11 | 11 | 10 | 11 | |||||
Line Of Credit | - | 0 | 0 | 1 | 1 | 1 | - | - | - | - | - | - | |||||
Liabilities Of Disposal Group Including Discontinu… | 5 | 6 | - | - | - | - | - | - | - | - | - | - | |||||
Other Liabilities Current | - | 1 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Liabilities Current | 16 | 25 | 20 | 21 | 22 | 20 | 20 | 18 | 18 | 18 | 15 | 17 | |||||
Long Term Debt Noncurrent | 13 | 13 | 19 | 19 | 19 | 19 | 18 | 22 | 25 | 25 | 26 | 26 | |||||
Security Deposit Liability | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 30 | 39 | 39 | 40 | 41 | 39 | 39 | 40 | 44 | 44 | 42 | 44 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Retained Earnings Accumulated Deficit | -15 | -21 | -20 | -21 | -21 | -20 | -20 | -18 | -19 | -18 | -14 | -12 | |||||
Stockholders Equity | 0 | -6 | -6 | -6 | -6 | -5 | -5 | -3 | -4 | -3 | 1 | 3 | |||||
Liabilities And Stockholders Equity | 30 | 33 | 33 | 34 | 35 | 33 | 34 | 37 | 40 | 41 | 42 | 47 | |||||
Deferred Finance Costs Current Net | - | - | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Debt Instrument Unamortized Discount Current | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
Debt Instrument Unamortized Discount Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Sales Inducements Net | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Deferred Finance Costs Noncurrent Net | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Dividends Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | - | |||||
Preferred Stock Dividend Rate Percentage | 0 | 0 | - | - | 0 | 0 | - | - | 0 | 0 | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 800 | 800 | 800 | 1,000 | 800 | 800 | 800 | 800 | 50 | 50 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 10.10% | 75.42% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 5.96% | 68.87% | 60.93% | 0.00% | -10.64% | -6.38% | -12.82% | 14.36% | 28.21% | -27.82% | -28.74% | 19.77% |
| 2024 | 0.00% | -20.00% | -20.00% | 0.00% | -12.50% | -11.50% | 43.38% | -8.09% | 47.06% | -9.09% | -31.36% | 2.27% |
| 2023 | 185.71% | 405.71% | 328.57% | -2.29% | -23.81% | -19.05% | -1.16% | -12.79% | -6.98% | 66.67% | 66.67% | 33.33% |
| 2022 | - | - | - | - | - | - | - | - | - | 0.00% | 10.53% | -36.84% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.60 | 0.30 | 0.19 | 0.19 | 0.22 | 0.18 | 0.17 | 0.33 | 0.23 | 0.27 | 0.40 | 0.60 | |||||
| Quick Ratio | 0.58 | 0.29 | 0.18 | 0.17 | 0.19 | 0.17 | 0.14 | 0.30 | 0.17 | 0.20 | 0.36 | 0.55 | |||||
| Working Capital | -6.50M | -17.69M | -16.34M | -17.23M | -16.77M | -16.10M | -16.66M | -12.27M | -13.95M | -13.19M | -8.80M | -6.73M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 115.17 | -6.25 | -6.89 | -6.26 | -6.68 | -7.18 | -8.02 | -12.41 | -10.87 | -14.72 | 61.56 | 15.40 | |||||
| Interest Coverage TTM | -0.81 | -0.60 | -0.37 | -0.58 | -0.60 | -0.65 | -2.37 | -2.98 | -3.36 | -4.12 | -3.44 | -2.22 | |||||
| Debt Ratio | 0.99 | 1.19 | 1.17 | 1.19 | 1.18 | 1.16 | 1.14 | 1.09 | 1.10 | 1.07 | 0.98 | 0.94 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.18 | 1.26 | 1.26 | 1.18 | 1.09 | 1.07 | 1.00 | 0.89 | 0.83 | 0.88 | 0.86 | 0.80 | |||||
| Days Sales Outstanding TTM | 25.60 | 21.55 | 22.07 | 23.09 | 21.19 | 21.76 | 18.74 | 23.29 | 23.28 | 24.79 | 25.10 | 37.61 | |||||
| Receivables Turnover TTM | 14.26 | 16.93 | 16.54 | 15.81 | 17.22 | 16.77 | 19.47 | 15.67 | 15.68 | 14.72 | 14.54 | 9.71 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.79 | -0.33 | -0.26 | -1.03 | -0.67 | -0.80 | -1.78 | -2.00 | -2.94 | -1.30 | -1.00 | -0.58 | |||||
| Free Cash Flow Per Share TTM | -0.67 | 0.47 | 0.14 | -0.35 | -0.44 | -0.67 | -1.13 | 0.04 | 0.23 | 0.16 | 0.84 | -0.25 | |||||
| Dividend Per Share TTM | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | - | - | 94.09% | 93.83% | 93.08% | |||||
| Operating Profit Margin TTM | -6.29% | -3.78% | -3.00% | -5.18% | -6.06% | -6.91% | -14.69% | -18.40% | -20.96% | -24.36% | -21.24% | -15.38% | |||||
| Net Profit Margin TTM | 16.12% | -2.45% | -1.90% | -7.65% | -5.09% | -6.19% | -14.29% | -16.42% | -24.63% | -10.80% | -8.22% | -4.72% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -5.54% | 4.94% | 10.10% | 10.76% | 10.41% | 7.36% | 3.39% | -0.67% | -8.59% | -9.40% | -10.38% | -3.82% | |||||
| Net Income Growth (1Y) | -399.32% | -58.48% | -85.33% | -48.39% | -77.19% | -38.39% | 79.77% | 245.64% | -762.48% | 63.70% | 100.61% | 205.87% | |||||
| EPS Growth (1Y) | -399.32% | -58.48% | -85.33% | -48.39% | -77.19% | -38.64% | 79.04% | 244.24% | -759.79% | 63.67% | 100.61% | 205.88% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 2.09 | -6.73 | -8.97 | -2.13 | -3.28 | -1.40 | -0.90 | -1.00 | -0.68 | -3.31 | -5.33 | -8.18 | |||||
| P/B TTM | 49.86 | -1.10 | -1.28 | -1.05 | -1.11 | -0.63 | -1.02 | -1.91 | -1.53 | -4.43 | 23.97 | 5.07 | |||||
| P/S TTM | 0.34 | 0.17 | 0.17 | 0.16 | 0.17 | 0.09 | 0.13 | 0.16 | 0.17 | 0.36 | 0.44 | 0.39 | |||||
| Market Cap | 12.88M | 6.84M | 7.21M | 6.75M | 6.75M | 3.44M | 4.91M | 6.13M | 6.13M | 13.13M | 16.22M | 14.51M | |||||
| Enterprise Value | 28.61M | 30.17M | 36.26M | 35.44M | 35.09M | 33.34M | 34.31M | 34.31M | 40.12M | 47.18M | 49.20M | 49.72M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -2.04M | 1.44M | 417.88K | -1.09M | -1.36M | -2.04M | -3.46M | 107.67K | 719.99K | 477.61K | 2.57M | -764.53K | |||||
| Net Debt | 15.73M | 23.33M | 29.05M | 28.69M | 28.34M | 29.90M | 29.40M | 28.17M | 33.99M | 34.04M | 32.98M | 35.21M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SELECTIS HEALTH, INC. (GBCS) — SEC Financial Statements & Analysis
SELECTIS HEALTH, INC. (GBCS) is a real estate investment trusts company, incorporated in UT. SELECTIS HEALTH, INC. trades on OTC as: GBCS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), SELECTIS HEALTH, INC. reported a -5.54% year-over-year revenue growth, a Gross Profit Margin of 94.09% (TTM), a Debt-to-Equity ratio of 115.17x, a Price-to-Sales (P/S) ratio of 0.34x (TTM), a Price-to-Book (P/B) ratio of 49.86x (TTM), at a market cap of $12.88M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -5.54%
- Gross Profit Margin TTM
- 94.09%
- Debt To Equity
- 115.17x
- P/S TTM
- 0.34x
- P/B TTM
- 49.86x
- Market Cap
- $12.88M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SELECTIS HEALTH, INC. in?
SELECTIS HEALTH, INC. (GBCS) operates in the Real Estate Investment Trusts industry.
What is GBCS's market cap?
SELECTIS HEALTH, INC. (GBCS) has a market capitalization of $12.88M as of 2026-03-31.
What is GBCS's P/E ratio?
SELECTIS HEALTH, INC. (GBCS)'s trailing twelve month P/E ratio is 2.09x as of 2026-03-31.
What exchange does GBCS trade on?
SELECTIS HEALTH, INC. (GBCS) trades on the OTC.
Where is SELECTIS HEALTH, INC. incorporated?
SELECTIS HEALTH, INC. is incorporated in UT.